- Home
- Publications
- Publication Search
- Publication Details
Title
MTOR inhibitor-based combination therapies for pancreatic cancer
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 118, Issue 3, Pages 366-377
Publisher
Springer Nature
Online
2018-01-03
DOI
10.1038/bjc.2017.421
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy
- (2017) Vincent Chung et al. JAMA Oncology
- mTORC2 Signaling Drives the Development and Progression of Pancreatic Cancer
- (2016) David R. Driscoll et al. CANCER RESEARCH
- Phosphoproteomics Reveals MAPK Inhibitors Enhance MET- and EGFR-Driven AKT Signaling in KRAS-Mutant Lung Cancer
- (2016) J.-Y. Kim et al. MOLECULAR CANCER RESEARCH
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update
- (2016) Enis Afgan et al. NUCLEIC ACIDS RESEARCH
- Heatmapper: web-enabled heat mapping for all
- (2016) Sasha Babicki et al. NUCLEIC ACIDS RESEARCH
- Pyruvate Kinase M2 and Lactate Dehydrogenase A Are Overexpressed in Pancreatic Cancer and Correlate with Poor Outcome
- (2016) Goran Hamid Mohammad et al. PLoS One
- Organoid Models of Human and Mouse Ductal Pancreatic Cancer
- (2015) Sylvia F. Boj et al. CELL
- MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer
- (2015) C. Garcia-Garcia et al. CLINICAL CANCER RESEARCH
- A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling
- (2015) Bo Kong et al. GUT
- mTOR Inhibition Induces EGFR Feedback Activation in Association with Its Resistance to Human Pancreatic Cancer
- (2015) Feng Wei et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The c-Myc–LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer
- (2015) Tian-Lin He et al. MEDICAL ONCOLOGY
- Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 Signaling
- (2015) Hee-Bum Kang et al. MOLECULAR CELL
- Therapy-induced tumour secretomes promote resistance and tumour progression
- (2015) Anna C. Obenauf et al. NATURE
- ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap
- (2015) Tauno Metsalu et al. NUCLEIC ACIDS RESEARCH
- KrasG12D induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cells
- (2015) S Diersch et al. ONCOGENE
- Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors
- (2015) Anneleen Daemen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors
- (2015) S N Payne et al. Oncogenesis
- Adaptive Responses to Dasatinib-Treated Lung Squamous Cell Cancer Cells Harboring DDR2 Mutations
- (2014) Y. Bai et al. CANCER RESEARCH
- Combined MEK and PI3K Inhibition in a Mouse Model of Pancreatic Cancer
- (2014) B. Alagesan et al. CLINICAL CANCER RESEARCH
- Tyrosine Phosphoproteomics Identifies Both Codrivers and Cotargeting Strategies for T790M-Related EGFR-TKI Resistance in Non-Small Cell Lung Cancer
- (2014) T. Yoshida et al. CLINICAL CANCER RESEARCH
- PI3K Regulation of RAC1 Is Required for KRAS-Induced Pancreatic Tumorigenesis in Mice
- (2014) Chia-Yen C. Wu et al. GASTROENTEROLOGY
- Pancreatic cell plasticity and cancer initiation induced by oncogenic Kras is completely dependent on wild-type PI 3-kinase p110α
- (2014) Romain Baer et al. GENES & DEVELOPMENT
- Targeting mTOR dependency in pancreatic cancer
- (2014) Douglas C Morran et al. GUT
- Suppression of Feedback Loops Mediated by PI3K/mTOR Induces Multiple Overactivation of Compensatory Pathways: An Unintended Consequence Leading to Drug Resistance
- (2014) E. Rozengurt et al. MOLECULAR CANCER THERAPEUTICS
- Modeling Targeted Inhibition of MEK and PI3 Kinase in Human Pancreatic Cancer
- (2014) M. R. Junttila et al. MOLECULAR CANCER THERAPEUTICS
- A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer
- (2014) Nina Schönhuber et al. NATURE MEDICINE
- Metabolic regulator LKB1 is crucial for Schwann cell–mediated axon maintenance
- (2014) Bogdan Beirowski et al. NATURE NEUROSCIENCE
- MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomib
- (2014) Matthias Wirth et al. NUCLEIC ACIDS RESEARCH
- Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: The discovery of AZD8055 and AZD2014
- (2013) Kurt G. Pike et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Web-based visual analysis for high-throughput genomics
- (2013) Jeremy Goecks et al. BMC GENOMICS
- Selective Requirement of PI3K/PDK1 Signaling for Kras Oncogene-Driven Pancreatic Cell Plasticity and Cancer
- (2013) Stefan Eser et al. CANCER CELL
- Dual Blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) Pathways Synergistically Inhibits Rhabdomyosarcoma Cell Growth In Vitro and In Vivo
- (2013) J. Renshaw et al. CLINICAL CANCER RESEARCH
- Resolving Molecular Events in the Regulation of Meiosis in Male and Female Germ Cells
- (2013) S. Kumar et al. Science Signaling
- Enhanced Apoptosis and Tumor Growth Suppression Elicited by Combination of MEK (Selumetinib) and mTOR Kinase Inhibitors (AZD8055)
- (2012) S. V. Holt et al. CANCER RESEARCH
- Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
- (2012) Haoqiang Ying et al. CELL
- Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
- (2012) Anirudh Prahallad et al. NATURE
- The translational landscape of mTOR signalling steers cancer initiation and metastasis
- (2012) Andrew C. Hsieh et al. NATURE
- Impact of Combined mTOR and MEK Inhibition in Uveal Melanoma Is Driven by Tumor Genotype
- (2012) Alan L. Ho et al. PLoS One
- Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages
- (2012) K. Clark et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Negative Feedback and Adaptive Resistance to the Targeted Therapy of Cancer
- (2012) Sarat Chandarlapaty Cancer Discovery
- Novel cross-talk within the IKK family controls innate immunity
- (2011) Kristopher Clark et al. BIOCHEMICAL JOURNAL
- Activation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote Tumorigenesis
- (2011) Alyssa L. Kennedy et al. MOLECULAR CELL
- Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies
- (2010) Milind M Javle et al. BMC CANCER
- Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer
- (2010) I Garrido-Laguna et al. BRITISH JOURNAL OF CANCER
- ROSA26Flpo deleter mice promote efficient inversion of conditional gene traps in vivo
- (2010) Christopher S. Raymond et al. GENESIS
- Activity of a novel, dual PI3-kinase/mTor inhibitor NVP-BEZ235 against primary human pancreatic cancers grown as orthotopic xenografts
- (2009) P Cao et al. BRITISH JOURNAL OF CANCER
- E-Cadherin Regulates Metastasis of Pancreatic Cancer In Vivo and Is Suppressed by a SNAIL/HDAC1/HDAC2 Repressor Complex
- (2009) Johannes von Burstin et al. GASTROENTEROLOGY
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now